Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853625) titled 'Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients' on Sept. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Health Sciences Lahore

Condition: Hypertension Left Ventricular Diastolic Dysfunction Essential (Primary) Hypertension

Intervention: Other: Sacubitril / Valsartan

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 102

To know more, visit https://cli...